4//SEC Filing
Bjorkquist Jeanette M 4
Accession 0001209191-23-021882
CIK 0001426800other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:40 PM ET
Size
12.7 KB
Accession
0001209191-23-021882
Insider Transaction Report
Form 4
Bjorkquist Jeanette M
Principal Accounting Officer
Transactions
- Award
Common Stock
2023-03-29+6,250→ 24,580 total - Award
Stock Option (right to buy)
2023-03-29+12,500→ 12,500 totalExercise: $0.89Exp: 2033-03-29→ Common Stock (12,500 underlying) - Sale
Common Stock
2023-03-30$0.82/sh−774$637→ 23,806 total - Award
Stock Option (right to buy)
2023-02-16+2,000→ 2,000 totalExercise: $1.53Exp: 2033-02-16→ Common Stock (2,000 underlying)
Footnotes (5)
- [F1]Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2024; March 29, 2025; March 29, 2026; and March 29, 2027.
- [F2]Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2022.
- [F3]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7795 to $0.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
- [F5]Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, February 16, 2024; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on February 16, 2027.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001945064
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:40 PM ET
- Size
- 12.7 KB